These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19699771)

  • 1. Nanoparticles made from novel starch derivatives for transdermal drug delivery.
    Santander-Ortega MJ; Stauner T; Loretz B; Ortega-Vinuesa JL; Bastos-González D; Wenz G; Schaefer UF; Lehr CM
    J Control Release; 2010 Jan; 141(1):85-92. PubMed ID: 19699771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytotoxicity evaluation of novel acylated starch nanoparticles.
    Thakore S; Valodkar M; Soni JY; Vyas K; Jadeja RN; Devkar RV; Rathore PS
    Bioorg Chem; 2013 Feb; 46():26-30. PubMed ID: 23247257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
    Yuan H; Jiang SP; Du YZ; Miao J; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2009 May; 70(2):248-53. PubMed ID: 19185474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive Eudragit nanoparticles for mucosal drug delivery.
    Yoo JW; Giri N; Lee CH
    Int J Pharm; 2011 Jan; 403(1-2):262-7. PubMed ID: 20971177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated starch acetate nanoparticles and its potential use for oral insulin delivery.
    Minimol PF; Paul W; Sharma CP
    Carbohydr Polym; 2013 Jun; 95(1):1-8. PubMed ID: 23618232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hydrophobic starch polymer for nanoparticle-mediated delivery of docetaxel.
    Dandekar P; Jain R; Stauner T; Loretz B; Koch M; Wenz G; Lehr CM
    Macromol Biosci; 2012 Feb; 12(2):184-94. PubMed ID: 22127828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticles.
    El-Naggar ME; El-Rafie MH; El-sheikh MA; El-Feky GS; Hebeish A
    Int J Biol Macromol; 2015 Nov; 81():718-29. PubMed ID: 26358550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and pharmaceutical evaluation of new sustained-release capsule including starch-sponge matrix (SSM).
    Shibata N; Nishumura A; Naruhashi K; Nakao Y; Miura R
    Biomed Pharmacother; 2010 May; 64(5):352-8. PubMed ID: 20006463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
    Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
    Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties.
    Schwarz JC; Weixelbaum A; Pagitsch E; Löw M; Resch GP; Valenta C
    Int J Pharm; 2012 Nov; 437(1-2):83-8. PubMed ID: 22903049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir.
    Ghera BB; Perret F; Chevalier Y; Parrot-Lopez H
    Int J Pharm; 2009 Jun; 375(1-2):155-62. PubMed ID: 19481701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device.
    Zvonar A; Kristl J; Kerc J; Grabnar PA
    J Microencapsul; 2009 Dec; 26(8):748-59. PubMed ID: 19888883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.